However, even after identifying its involvement in development and progression to tumour relapse, the details about the regulatory pathways still are missing, further studies which highlight these missing links can help in finally helping the potential of HNF1B to become a biomarker in different cancers. This evidence concerns the gene HNF1B and cancer.